Eidos Therapeutics has just one experimental drug in a rare, fatal genetic disease, but it has moved the drug into the clinic quickly.
Ron Leuty, Biz Journals
Sat, 05/26/2018 - 9:15am
Eidos Therapeutics has just one experimental drug in a rare, fatal genetic disease, but it has moved the drug into the clinic quickly.